Edition:
United Kingdom

Microbot Medical Inc (MBOT.OQ)

MBOT.OQ on NASDAQ Stock Exchange Capital Market

5.80USD
8:35pm BST
Change (% chg)

$-0.15 (-2.52%)
Prev Close
$5.95
Open
$5.86
Day's High
$5.99
Day's Low
$5.65
Volume
7,794
Avg. Vol
6,777
52-wk High
$19.35
52-wk Low
$5.51

Chart for

About

Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product... (more)

Overall

Beta: -0.48
Market Cap(Mil.): $45.59
Shares Outstanding(Mil.): 34.81
Dividend: --
Yield (%): --

Financials

  MBOT.OQ Industry Sector
P/E (TTM): -- 85.91 32.75
EPS (TTM): -0.79 -- --
ROI: -319.02 1.70 14.60
ROE: -349.88 3.17 16.33

BRIEF-Microbot Medical Exercises Option To Buy Novel Technology From Cardiosert

* MICROBOT MEDICAL EXERCISES OPTION TO ACQUIRE NOVEL TECHNOLOGY FROM CARDIOSERT LTD. Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

16 Apr 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF82.46 +0.46
Pfizer Inc. (PFE.N) $43.12 -0.66
Roche Holding Ltd. (ROG.S) CHF235.25 -0.30
Roche Holding Ltd. (RO.S) CHF236.60 +0.60
Merck & Co., Inc. (MRK.N) $69.46 -0.35
Sanofi SA (SASY.PA) €75.29 +1.51
Abbott Laboratories (ABT.N) $68.70 -0.63
Amgen, Inc. (AMGN.OQ) $195.59 -1.80
Merck KGaA (MRCG.DE) €88.38 +2.12
Biogen Inc (BIIB.OQ) $328.41 -2.53

Earnings vs. Estimates